A 3D QSAR study of monoamino oxidase-B inhibitors using the chemical function based pharmacophore generation approach

被引:25
作者
Gritsch, S
Guccione, S
Hoffmann, RM
Cambria, A
Raciti, G
Langer, T
机构
[1] Univ Catania, Dipartimento Sci Farmaceut, I-95125 Catania, Italy
[2] Univ Innsbruck, Dept Pharmaceut Chem, Inst Pharm, A-6020 Innsbruck, Austria
[3] Parc Club Orsay Univ, F-91898 Orsay, France
[4] Univ Catania, Dipartimento Sci Chim, Sect Biochem & Mol Biol, I-95125 Catania, Italy
来源
JOURNAL OF ENZYME INHIBITION | 2001年 / 16卷 / 03期
关键词
catalyst software; thiazole and thiosemicarbazide derivatives; MAO-B inhibitors; 3D database searching;
D O I
10.1080/14756360109162369
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
A molecular modelling study was performed using the CATALYST software package on a dataset of 100 thiosemicarbazide and thiazole derivatives acting as MAO-B irreversible inhibitors in order to, (i) better elucidate the possible role of the ligand features which are significant for binding and (ii) generate chemical features based pharmacophore models which were subsequently used as 3D queries for database searching. Based on known MAO-B inhibitors, pharmacophore hypotheses were created in order to find similarities between the thiazoles and thiosemicarbazides and identify the key sub-structures most likely to be significant for high MAO-B inhibitory activity.
引用
收藏
页码:199 / +
页数:21
相关论文
共 44 条
[1]
ALLAIN H, 1997, PROGR MED CHEM
[2]
Inhibition of monoamine oxidase-B by condensed pyridazines and pyrimidines: Effects of lipophilicity and structure-activity relationships [J].
Altomare, C ;
Cellamare, S ;
Summo, L ;
Catto, M ;
Carotti, A ;
Thull, U ;
Carrupt, PA ;
Testa, B ;
Stoeckli-Evans, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (20) :3812-3820
[3]
Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice [J].
Alvarez, JC ;
Sanceaume, M ;
Advenier, C ;
Spreux-Varoquaux, O .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1999, 10 (01) :31-36
[4]
CDNA CLONING OF HUMAN-LIVER MONOAMINE OXIDASE-A AND OXIDASE-B - MOLECULAR-BASIS OF DIFFERENCES IN ENZYMATIC-PROPERTIES [J].
BACH, AWJ ;
LAN, NC ;
JOHNSON, DL ;
ABELL, CW ;
BEMBENEK, ME ;
KWAN, SW ;
SEEBURG, PH ;
SHIH, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4934-4938
[5]
Identification of common functional configurations among molecules [J].
Barnum, D ;
Greene, J ;
Smellie, A ;
Sprague, P .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1996, 36 (03) :563-571
[6]
BENEDETTI MS, 1988, PROG DRUG METAB, V11, P149
[7]
SELECTIVE AND POTENT MONOAMINE-OXIDASE TYPE-B INHIBITORS - SUBSTITUTED SEMICARBAZONES AND ACYLHYDRAZONES OF AROMATIC-ALDEHYDES AND KETONES [J].
BERNARD, S ;
PAILLAT, C ;
ODDOS, T ;
SEMAN, M ;
MILCENT, R .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1995, 30 (06) :471-482
[8]
Protective and symptomatic strategies for therapy of Parkinson's disease [J].
Blandini, F ;
Greenamyre, JT .
DRUGS OF TODAY, 1999, 35 (06) :473-483
[9]
Monoamine oxidase molecular activity in platelets of parkinsonian and demented patients [J].
Bongioanni, P ;
Mondino, C ;
Boccardi, B ;
Borgna, M ;
Castagna, M .
NEURODEGENERATION, 1996, 5 (04) :351-357
[10]
Structure-activity studies on monoamine oxidase inhibitors by calorimetric and quantum mechanical calculations [J].
Cambria, A ;
Raudino, A ;
Castelli, F ;
Raciti, G ;
Mazzone, P ;
Buemi, G ;
Pignatello, R ;
Mazzone, G .
JOURNAL OF ENZYME INHIBITION, 1996, 10 (04) :215-229